Sensorium Therapeutics Appoints Sam Rasty, Ph.D., As Chief Business Officer
Apr 17, 2024•over 1 year ago
Position
Chief Business Officer
Company
Sensorium Therapeutics
Description
Sensorium Therapeutics announced the appointment of Sam Rasty, Ph.D., as Chief Business Officer. Dr. Rasty brings over 25 years of experience in R&D, business development, and commercial strategies, with a focus on advancing novel medicines to treat CNS disorders
Executive Insights
Based on hiring dataNew executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months